Table 3.
Characteristics of patients with hepatocellular carcinoma and mixed carcinoma
|
Frequencies
|
Range/percentage
|
Incision margin (cm) | 1.18 ± 1.0 | 0-20 |
Liver cirrhosis | ||
Cirrhosis | 201 | 43.04% |
Non | 266 | 56.96% |
Tumor location | ||
Central | 229 | 49.03% |
Marginal | 238 | 50.97% |
BCLC stage | ||
0 | 81 | 17.34% |
A1 | 245 | 52.46% |
A2 | 40 | 8.57% |
A3 | 22 | 4.71% |
A4 | 14 | 3.00% |
B | 48 | 10.27% |
C | 17 | 3.64% |
D | 0 | 0 |
TNM stage | ||
Ia | 302 | 64.66% |
Ib | 99 | 21.20% |
IIa | 43 | 9.21% |
IIb | 15 | 3.21% |
IIIa | 7 | 1.50% |
IIIb | 1 | 0.21% |
IV | 0 | 0 |
Liver capsule invasion | ||
Positive | 156 | 33.40% |
Differentiation | 311 | 66.60% |
Well-moderate | 275 | 58.87% |
Poor | 192 | 41.13% |
BCLC: Barcelona Clinic Liver Cancer; TNM: Tumor-node-metastasis.